Effects of glucagon-like peptide-1 (GLP-1) on glucose homeostasis and food intake.
Balkan
B
B
Novartis Institute for Biomedical Research, LSB 3517, 556 Morris Ave, Summit, NJ 07901, USA. bork.balkan@ipd-discovery.com
D000818:Animals; D018819:Dipeptidyl Peptidase 4 / Q000008:administration & dosage / Q000378:metabolism; D004435:Eating / Q000187:drug effects / Q000502:physiology; D005247:Feeding Behavior; D005934:Glucagon; D052216:Glucagon-Like Peptide 1; D004763:Glucagon-Like Peptides; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology; D007328:Insulin / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D009570:Nitriles / Q000494:pharmacology; D010446:Peptide Fragments / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D011480:Protease Inhibitors / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats
C121834:1-(((2-((5-cyanopyridin-2-yl)amino)ethyl)amino)acetyl)-2-cyano-(S)-pyrrolidine; D007328:Insulin; D018377:Neurotransmitter Agents; D009570:Nitriles; D010446:Peptide Fragments; D011480:Protease Inhibitors; D011759:Pyrrolidines; C055453:glucagon-like peptide 1 (7-36)amide; D004763:Glucagon-Like Peptides; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D018819:Dipeptidyl Peptidase 4; D005947:Glucose